Literature DB >> 3113776

Genetic factors in Graves' ophthalmopathy.

M Frecker, V Stenszky, C Balazs, L Kozma, E Kraszits, N R Farid.   

Abstract

We investigated the distribution of HLA and immunoglobulin G heavy chain markers (Gm) in 117 patients with Graves' disease, 62 with ophthalmopathy and 55 without. With Graves' disease per se, there is a closer association with HLA-DR3 than with B8. The opposite was true for Graves' patients with ophthalmopathy (odds ratio for ophthalmopathy associated with B8 was 12.4 and with DR3 was 7.7, both with P less than 0.0005). HLA-DR7 interacts with B8 in modifying the risk for eye disease; using the phenotype B8- DR7- as reference, the odds ratios were 16.7 for B8+ DR7+, 8.7 for B8+ DR7- and 0.26 for B8- DR7+. Thus, DR7 enhanced the risk for ophthalmopathy in the presence of B8+ but had a protective influence in its absence. Although Gm showed no association with eye disease, it modified the risk for ophthalmopathy associated with HLA-B8; the odds ratios were 20.9 for B8+ Gmfb homozygozity (fb+), 15.3 for B8+ fb- and 1.7 for B8- fb+ (B8- fb- = 1.00). We conclude that the genetic factors contributing to Graves' ophthalmopathy are different from those related to liability for Graves' hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3113776     DOI: 10.1111/j.1365-2265.1986.tb03599.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  15 in total

1.  Genetics of thyroid-associated ophthalmopathy: a play in search of a cast of characters.

Authors:  N R Farid; M Marga
Journal:  J Endocrinol Invest       Date:  2003-06       Impact factor: 4.256

2.  HLA-DRB3 gene alleles in Caucasian patients with Graves' disease.

Authors:  B O Boehm; P Kühnl; B J Manfras; M Chen; J C Lee; G Holzberger; S Seidl; E Schifferdecker; P M Schumm-Draeger; K H Usadel
Journal:  Clin Investig       Date:  1992-10

3.  Immunogenetic markers in patients with Graves' disease.

Authors:  E Schifferdecker; P Kühnl; K Schöffling; B Manfras; G Holzberger; W Spielmann; B O Böhm
Journal:  Klin Wochenschr       Date:  1991-04-04

Review 4.  Autoimmunity in Graves' ophthalmopathy: a review.

Authors:  A P Weetman
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

5.  HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patients.

Authors:  R van der Gaag; W M Wiersinga; L Koornneef; M P Mourits; M F Prummel; A Berghout; R R de Vries; G M Schreuder; J D'Amaro
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

Review 6.  Pathogenesis of ophthalmopathy in autoimmune thyroid disease.

Authors:  A E Heufelder
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

7.  Human lymphocyte antigens (HLA) and Graves' disease in Turkey.

Authors:  Y Orhan; A Azezli; M Carin; F Aral; E Sencer; S Molvalilar
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

8.  Antibodies to acetylcholinesterase cross-reacting with thyroglobulin in myasthenia gravis and Graves's disease.

Authors:  D G Mappouras; G Philippou; S Haralambous; S J Tzartos; A Balafas; A Souvatzoglou; P Lymberi
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

9.  Association between age at diagnosis of Graves' disease and variants in genes involved in immune response.

Authors:  Beata Jurecka-Lubieniecka; Rafal Ploski; Dorota Kula; Aleksandra Krol; Tomasz Bednarczuk; Zofia Kolosza; Andrzej Tukiendorf; Sylwia Szpak-Ulczok; Anita Stanjek-Cichoracka; Joanna Polanska; Barbara Jarzab
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

10.  Association of MICA Alleles with Autoimmune Thyroid Disease in Korean Children.

Authors:  Won Kyoung Cho; Min Ho Jung; So Hyun Park; In Cheol Baek; Hee-Baeg Choi; Tai-Gyu Kim; Byung-Kyu Suh
Journal:  Int J Endocrinol       Date:  2012-11-14       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.